Benufutamab (GEN1029) is a death рецептор 5 (DR5)-specific agonistic антитело. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects.
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.